Curated News
By: NewsRamp Editorial Staff
June 11, 2026

UNLOCKD Reports 76% Revenue Growth at Ancient Extracts

Discuss on LinkedIn Discuss on X, formerly Twitter Discuss on Substack Discuss on Telegram participate in discussion on bluesky Participate in discussion on Mastodon View History of this news story on GitHub
Original Source

TLDR

  • UNLOCKD's Ancient Extracts shows 76% monthly revenue growth and a $58,823 purchase order, signaling early acquisition success.
  • UNLOCKD acquired Ancient Extracts in mid-May; preliminary unaudited May revenue hit $22,344, with a June purchase order at wholesale pricing.
  • Ancient Extracts offers functional mushroom and wellness products, promoting natural health remedies for modern life.
  • UNLOCKD's division begins evaluating point-of-care testing concepts, exploring future health technology opportunities.

Impact - Why it Matters

This news matters because it demonstrates early validation of UNLOCKD's acquisition strategy, with Ancient Extracts showing strong month-over-month revenue growth and significant purchase orders. For investors and wellness industry observers, it suggests that the company's shift toward functional mushroom and adaptogen products is gaining traction in a market increasingly focused on natural health solutions. The partial-month revenue figure and subsequent order indicate accelerating demand, potentially positioning UNLOCKD for sustained growth in the competitive wellness sector. Moreover, the cautious yet optimistic tone from management, combined with a disciplined approach to expansion, builds credibility around the company's ability to execute and create long-term shareholder value.

Summary

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as UNLOCKD Inc., has released a promising commercialization update for its recently acquired subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA. The company reported preliminary May revenue of approximately $22,344, a 76% month-over-month increase from April's $12,670. Notably, this revenue reflects only a partial month of operations under UNLOCKD ownership, as the acquisition closed mid-May. Additionally, on June 2, 2026, Ancient Extracts received a purchase order worth approximately $58,823 in retail product value, with a wholesale equivalent of $29,411. These early results underscore the momentum of the merger, as highlighted by CEO John P. Gorst, who emphasized disciplined execution and sustainable growth. The company's focus on functional mushroom products, ceremonial teas, cacao blends, matcha, shilajit, and other wellness goods aligns with growing consumer interest in adaptogens and botanical health solutions.

Chairman and Chief Science Officer Dr. Jordan P. Balencic expressed confidence in Ancient Extracts' differentiated portfolio and capital-efficient model, which provides a strong foundation for future expansion. The company plans to leverage this platform for strategic partnerships, product innovation, and broader growth in wellness, cognitive health, and human optimization. Separately, UNLOCKD Technologies has initiated preliminary planning for point-of-care testing concepts, though these remain in early conceptual stages and will seek dedicated financing. The company intends to pursue milestone-driven development without diverting capital from current operations.

This update signals UNLOCKD's transition into a revenue-generating wellness platform. For more details, visit the original release on NEWMEDIAWIRE.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, UNLOCKD Reports 76% Revenue Growth at Ancient Extracts

blockchain registration record for this content.